<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Beigel</surname>
    <given-names>J. H.</given-names>
   </name>
   <name>
    <surname>Nam</surname>
    <given-names>H. H.</given-names>
   </name>
   <name>
    <surname>Adams</surname>
    <given-names>P. L.</given-names>
   </name>
   <name>
    <surname>Krafft</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Ince</surname>
    <given-names>W. L.</given-names>
   </name>
   <name>
    <surname>El-Kamary</surname>
    <given-names>S. S.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Advances in respiratory virus therapeutics – a meeting report from the 6th isirv antiviral group conference</article-title>. 
  <source>Antiviral Res.</source>
  <volume>167</volume>, 
  <fpage>45</fpage>–
  <lpage>67</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2019.04.006</pub-id>
  <?supplied-pmid 30974127?>
  <pub-id pub-id-type="pmid">30974127</pub-id>
 </mixed-citation>
</ref>
